Katherine E. A. Semrau, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Delivery, Obstetric | 25 | 2024 | 939 | 4.720 |
Why?
|
Checklist | 20 | 2024 | 827 | 4.330 |
Why?
|
Parturition | 18 | 2024 | 447 | 3.530 |
Why?
|
Chlorhexidine | 7 | 2022 | 160 | 2.710 |
Why?
|
Infant Mortality | 16 | 2023 | 751 | 2.230 |
Why?
|
Maternal Health Services | 8 | 2022 | 460 | 2.170 |
Why?
|
World Health Organization | 13 | 2024 | 1321 | 2.100 |
Why?
|
Maternal Mortality | 12 | 2021 | 301 | 1.850 |
Why?
|
Perinatal Mortality | 8 | 2021 | 101 | 1.810 |
Why?
|
Zambia | 35 | 2023 | 262 | 1.790 |
Why?
|
Anti-Infective Agents, Local | 6 | 2021 | 247 | 1.750 |
Why?
|
Umbilical Cord | 5 | 2018 | 177 | 1.730 |
Why?
|
India | 21 | 2024 | 2286 | 1.590 |
Why?
|
Midwifery | 5 | 2020 | 125 | 1.370 |
Why?
|
Milk, Human | 13 | 2023 | 486 | 1.240 |
Why?
|
Infant, Low Birth Weight | 6 | 2024 | 869 | 1.180 |
Why?
|
Infant, Newborn | 54 | 2024 | 26180 | 1.160 |
Why?
|
Oxytocin | 2 | 2021 | 402 | 1.150 |
Why?
|
Pregnancy | 53 | 2024 | 29868 | 1.070 |
Why?
|
Breast Feeding | 20 | 2024 | 1354 | 1.060 |
Why?
|
Guideline Adherence | 7 | 2021 | 2218 | 1.050 |
Why?
|
Perinatal Care | 2 | 2019 | 244 | 0.990 |
Why?
|
Infectious Disease Transmission, Vertical | 15 | 2017 | 1351 | 0.800 |
Why?
|
Nurses | 2 | 2020 | 2477 | 0.690 |
Why?
|
Nurse Midwives | 1 | 2020 | 23 | 0.690 |
Why?
|
Equipment and Supplies | 2 | 2019 | 273 | 0.660 |
Why?
|
Infant Formula | 1 | 2021 | 193 | 0.660 |
Why?
|
Nevirapine | 7 | 2013 | 273 | 0.660 |
Why?
|
Breast Diseases | 2 | 2013 | 443 | 0.630 |
Why?
|
Evidence-Based Practice | 2 | 2020 | 494 | 0.610 |
Why?
|
HIV Infections | 31 | 2019 | 17337 | 0.600 |
Why?
|
Resuscitation | 2 | 2022 | 672 | 0.590 |
Why?
|
Aftercare | 2 | 2022 | 913 | 0.590 |
Why?
|
Skin Diseases, Bacterial | 1 | 2018 | 67 | 0.580 |
Why?
|
Pregnant Women | 1 | 2022 | 567 | 0.560 |
Why?
|
Peer Group | 2 | 2020 | 692 | 0.550 |
Why?
|
Quality of Health Care | 7 | 2022 | 4321 | 0.530 |
Why?
|
Program Evaluation | 5 | 2019 | 2486 | 0.520 |
Why?
|
Child Health Services | 2 | 2019 | 644 | 0.520 |
Why?
|
Developing Countries | 7 | 2023 | 2867 | 0.510 |
Why?
|
Infant | 38 | 2024 | 36152 | 0.500 |
Why?
|
Community Health Services | 2 | 2018 | 654 | 0.500 |
Why?
|
Quality Improvement | 12 | 2021 | 3797 | 0.480 |
Why?
|
Cesarean Section | 3 | 2022 | 1396 | 0.470 |
Why?
|
Obstetrics | 1 | 2021 | 666 | 0.470 |
Why?
|
Female | 88 | 2024 | 392148 | 0.450 |
Why?
|
Emergency Treatment | 1 | 2017 | 495 | 0.440 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 3194 | 0.430 |
Why?
|
Stillbirth | 3 | 2023 | 368 | 0.420 |
Why?
|
RNA, Viral | 7 | 2013 | 2838 | 0.400 |
Why?
|
Pregnancy Complications | 4 | 2023 | 2948 | 0.400 |
Why?
|
Infant, Premature | 2 | 2023 | 2107 | 0.400 |
Why?
|
Surgical Wound Infection | 1 | 2021 | 1529 | 0.390 |
Why?
|
HIV-1 | 10 | 2017 | 6858 | 0.380 |
Why?
|
Birth Weight | 8 | 2023 | 2101 | 0.370 |
Why?
|
Caregivers | 1 | 2023 | 2241 | 0.370 |
Why?
|
Weaning | 7 | 2010 | 103 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 9 | 2015 | 2149 | 0.350 |
Why?
|
Patient Education as Topic | 2 | 2020 | 2315 | 0.350 |
Why?
|
Sepsis | 2 | 2021 | 2585 | 0.330 |
Why?
|
Malawi | 4 | 2024 | 302 | 0.330 |
Why?
|
Abscess | 1 | 2013 | 606 | 0.330 |
Why?
|
Delivery of Health Care, Integrated | 2 | 2016 | 940 | 0.330 |
Why?
|
Prenatal Care | 4 | 2023 | 1140 | 0.320 |
Why?
|
Humans | 96 | 2024 | 760617 | 0.320 |
Why?
|
Patient Care Team | 2 | 2016 | 2515 | 0.300 |
Why?
|
Adaptation, Psychological | 1 | 2018 | 2629 | 0.290 |
Why?
|
Health Facilities | 4 | 2020 | 578 | 0.280 |
Why?
|
Bacterial Infections | 1 | 2015 | 1389 | 0.270 |
Why?
|
Mothers | 7 | 2023 | 2194 | 0.270 |
Why?
|
Puerperal Disorders | 2 | 2020 | 300 | 0.260 |
Why?
|
Counseling | 3 | 2019 | 1538 | 0.240 |
Why?
|
Quality Indicators, Health Care | 4 | 2020 | 1790 | 0.240 |
Why?
|
Malaria | 4 | 2012 | 1226 | 0.240 |
Why?
|
Chloroquine | 1 | 2006 | 274 | 0.240 |
Why?
|
Antimalarials | 3 | 2012 | 907 | 0.230 |
Why?
|
Postpartum Period | 4 | 2023 | 1178 | 0.220 |
Why?
|
Tanzania | 3 | 2024 | 1390 | 0.220 |
Why?
|
Cluster Analysis | 2 | 2021 | 2700 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 10199 | 0.210 |
Why?
|
Anti-HIV Agents | 7 | 2013 | 4524 | 0.200 |
Why?
|
Infant, Newborn, Diseases | 2 | 2018 | 589 | 0.180 |
Why?
|
Mastitis | 2 | 2013 | 43 | 0.180 |
Why?
|
Private Sector | 1 | 2022 | 394 | 0.170 |
Why?
|
Patient Discharge | 3 | 2022 | 3442 | 0.170 |
Why?
|
Adult | 30 | 2024 | 220969 | 0.160 |
Why?
|
Thinness | 1 | 2023 | 480 | 0.160 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2023 | 369 | 0.160 |
Why?
|
Depression, Postpartum | 1 | 2023 | 349 | 0.160 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2021 | 407 | 0.150 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2021 | 351 | 0.150 |
Why?
|
CD4 Lymphocyte Count | 7 | 2009 | 2567 | 0.150 |
Why?
|
Health Knowledge, Attitudes, Practice | 5 | 2019 | 4007 | 0.150 |
Why?
|
Community-Institutional Relations | 1 | 2019 | 206 | 0.150 |
Why?
|
Obstetric Labor Complications | 1 | 2020 | 236 | 0.150 |
Why?
|
HIV | 3 | 2009 | 1579 | 0.140 |
Why?
|
Information Seeking Behavior | 1 | 2018 | 116 | 0.140 |
Why?
|
Peer Review | 1 | 2019 | 217 | 0.140 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.140 |
Why?
|
Intention to Treat Analysis | 1 | 2017 | 413 | 0.140 |
Why?
|
Postnatal Care | 2 | 2018 | 260 | 0.130 |
Why?
|
Africa South of the Sahara | 4 | 2022 | 745 | 0.120 |
Why?
|
Home Childbirth | 2 | 2013 | 54 | 0.120 |
Why?
|
Research Design | 4 | 2024 | 6174 | 0.120 |
Why?
|
Fetal Death | 1 | 2016 | 435 | 0.120 |
Why?
|
Shame | 1 | 2015 | 80 | 0.120 |
Why?
|
Polymerase Chain Reaction | 4 | 2013 | 6074 | 0.120 |
Why?
|
Anti-Retroviral Agents | 3 | 2015 | 1782 | 0.110 |
Why?
|
Viral Load | 6 | 2009 | 3325 | 0.110 |
Why?
|
Standard of Care | 1 | 2017 | 551 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Professional-Patient Relations | 1 | 2019 | 724 | 0.110 |
Why?
|
Ethanolamines | 2 | 2012 | 153 | 0.110 |
Why?
|
Rural Population | 5 | 2017 | 2276 | 0.110 |
Why?
|
Prospective Studies | 10 | 2024 | 54360 | 0.110 |
Why?
|
Pre-Eclampsia | 1 | 2022 | 1230 | 0.110 |
Why?
|
Neonatal Screening | 1 | 2017 | 597 | 0.110 |
Why?
|
HIV Seropositivity | 4 | 2013 | 959 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2018 | 637 | 0.110 |
Why?
|
Fluorenes | 2 | 2012 | 157 | 0.100 |
Why?
|
Health Care Surveys | 2 | 2017 | 2423 | 0.100 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1110 | 0.100 |
Why?
|
Health Services Research | 2 | 2017 | 1808 | 0.100 |
Why?
|
Public Health Administration | 1 | 2015 | 241 | 0.100 |
Why?
|
Hypothermia | 1 | 2014 | 188 | 0.100 |
Why?
|
Selection, Genetic | 1 | 2017 | 868 | 0.100 |
Why?
|
Child Abuse, Sexual | 1 | 2015 | 403 | 0.100 |
Why?
|
Artemisinins | 2 | 2012 | 218 | 0.100 |
Why?
|
Reproductive Health Services | 1 | 2012 | 87 | 0.100 |
Why?
|
Gestational Age | 2 | 2017 | 3577 | 0.100 |
Why?
|
Cohort Studies | 9 | 2024 | 41457 | 0.100 |
Why?
|
Chi-Square Distribution | 1 | 2017 | 3410 | 0.090 |
Why?
|
Health Behavior | 2 | 2018 | 2643 | 0.090 |
Why?
|
Practice Guidelines as Topic | 2 | 2020 | 7389 | 0.090 |
Why?
|
Communications Media | 1 | 2011 | 42 | 0.090 |
Why?
|
Clinical Protocols | 1 | 2016 | 1437 | 0.090 |
Why?
|
Medication Adherence | 2 | 2015 | 2174 | 0.090 |
Why?
|
Neglected Diseases | 1 | 2011 | 66 | 0.090 |
Why?
|
Stereotyping | 1 | 2012 | 239 | 0.090 |
Why?
|
Vietnam | 3 | 2019 | 406 | 0.090 |
Why?
|
Mass Screening | 3 | 2019 | 5424 | 0.090 |
Why?
|
Analysis of Variance | 1 | 2019 | 6224 | 0.090 |
Why?
|
Culture | 1 | 2013 | 623 | 0.080 |
Why?
|
Health Services Accessibility | 3 | 2017 | 5430 | 0.080 |
Why?
|
Desiccation | 1 | 2009 | 78 | 0.080 |
Why?
|
Parents | 1 | 2023 | 3563 | 0.080 |
Why?
|
Pneumonia, Bacterial | 1 | 2012 | 315 | 0.080 |
Why?
|
Interleukin-15 | 1 | 2009 | 185 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5866 | 0.080 |
Why?
|
Algorithms | 3 | 2018 | 14018 | 0.080 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20074 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 2003 | 0.080 |
Why?
|
Prejudice | 1 | 2012 | 571 | 0.080 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2010 | 303 | 0.080 |
Why?
|
Asia | 2 | 2021 | 615 | 0.070 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7798 | 0.070 |
Why?
|
Drug Combinations | 3 | 2012 | 2048 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3333 | 0.070 |
Why?
|
Parity | 3 | 2023 | 924 | 0.070 |
Why?
|
Leadership | 1 | 2016 | 1385 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2164 | 0.070 |
Why?
|
Child | 6 | 2023 | 80079 | 0.070 |
Why?
|
Interleukin-7 | 1 | 2007 | 143 | 0.070 |
Why?
|
Domestic Violence | 2 | 2006 | 180 | 0.070 |
Why?
|
Specimen Handling | 2 | 2009 | 701 | 0.070 |
Why?
|
Blood | 1 | 2009 | 596 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 13245 | 0.070 |
Why?
|
Sulfadoxine | 1 | 2006 | 46 | 0.070 |
Why?
|
Time Factors | 6 | 2016 | 39913 | 0.070 |
Why?
|
Public Sector | 2 | 2018 | 264 | 0.070 |
Why?
|
Genotype | 3 | 2017 | 12978 | 0.070 |
Why?
|
Pyrimethamine | 1 | 2006 | 94 | 0.070 |
Why?
|
Male | 16 | 2024 | 360358 | 0.060 |
Why?
|
Internationality | 1 | 2011 | 1000 | 0.060 |
Why?
|
alpha-Defensins | 1 | 2005 | 30 | 0.060 |
Why?
|
Divorce | 1 | 2005 | 76 | 0.060 |
Why?
|
Risk Factors | 7 | 2021 | 74115 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14648 | 0.060 |
Why?
|
Attitude to Health | 1 | 2013 | 2024 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26049 | 0.060 |
Why?
|
DNA, Viral | 2 | 2009 | 2195 | 0.060 |
Why?
|
Risk Assessment | 4 | 2021 | 23972 | 0.060 |
Why?
|
Patient Compliance | 4 | 2009 | 2688 | 0.060 |
Why?
|
Prolactin | 1 | 2006 | 625 | 0.060 |
Why?
|
Health Status | 1 | 2016 | 4075 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2012 | 1213 | 0.050 |
Why?
|
Lactation | 1 | 2005 | 397 | 0.050 |
Why?
|
Fever | 1 | 2010 | 1618 | 0.050 |
Why?
|
Emergency Medical Services | 1 | 2014 | 1921 | 0.050 |
Why?
|
Sodium | 1 | 2008 | 1588 | 0.050 |
Why?
|
Treatment Refusal | 1 | 2006 | 429 | 0.050 |
Why?
|
Pneumonia | 2 | 2011 | 2143 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2024 | 347 | 0.050 |
Why?
|
Family | 1 | 2012 | 3193 | 0.050 |
Why?
|
Infant Care | 2 | 2014 | 180 | 0.050 |
Why?
|
Cachexia | 1 | 2023 | 202 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 59179 | 0.050 |
Why?
|
Hospitals | 1 | 2014 | 3877 | 0.050 |
Why?
|
Infant, Small for Gestational Age | 1 | 2023 | 462 | 0.040 |
Why?
|
Violence | 1 | 2006 | 936 | 0.040 |
Why?
|
Family Characteristics | 1 | 2005 | 992 | 0.040 |
Why?
|
Survival Analysis | 2 | 2010 | 10073 | 0.040 |
Why?
|
Polymorphism, Genetic | 1 | 2010 | 4242 | 0.040 |
Why?
|
Case Management | 2 | 2012 | 272 | 0.040 |
Why?
|
Disclosure | 1 | 2005 | 747 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15828 | 0.040 |
Why?
|
Behavior Therapy | 1 | 2004 | 877 | 0.040 |
Why?
|
Adolescent | 6 | 2021 | 88234 | 0.040 |
Why?
|
Mortality | 1 | 2010 | 2899 | 0.040 |
Why?
|
Child Abuse | 1 | 2006 | 1076 | 0.040 |
Why?
|
Hemoglobins | 1 | 2023 | 1524 | 0.040 |
Why?
|
Mexico | 1 | 2019 | 756 | 0.030 |
Why?
|
Administration, Topical | 1 | 2018 | 703 | 0.030 |
Why?
|
Spouses | 1 | 2018 | 283 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1550 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2016 | 64568 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1790 | 0.030 |
Why?
|
Nutritional Status | 1 | 2023 | 1596 | 0.030 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 529 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2017 | 461 | 0.030 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2014 | 56 | 0.030 |
Why?
|
Qualitative Research | 2 | 2019 | 3016 | 0.030 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 369 | 0.030 |
Why?
|
Risk-Taking | 1 | 2019 | 1037 | 0.030 |
Why?
|
Rural Health | 1 | 2014 | 296 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 673 | 0.030 |
Why?
|
Reproductive Rights | 1 | 2012 | 31 | 0.030 |
Why?
|
Women's Rights | 1 | 2012 | 65 | 0.030 |
Why?
|
Personnel, Hospital | 1 | 2014 | 285 | 0.030 |
Why?
|
Body Temperature Regulation | 1 | 2014 | 292 | 0.030 |
Why?
|
Health Promotion | 1 | 2004 | 2206 | 0.030 |
Why?
|
Public Health | 2 | 2018 | 2669 | 0.020 |
Why?
|
Child Development | 1 | 2024 | 2300 | 0.020 |
Why?
|
Child, Preschool | 5 | 2014 | 42188 | 0.020 |
Why?
|
Homosexuality, Male | 1 | 2019 | 1333 | 0.020 |
Why?
|
Amoxicillin | 1 | 2012 | 180 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2921 | 0.020 |
Why?
|
Genes, env | 1 | 2010 | 95 | 0.020 |
Why?
|
HIV Envelope Protein gp160 | 1 | 2010 | 92 | 0.020 |
Why?
|
Human Rights | 1 | 2012 | 309 | 0.020 |
Why?
|
HIV-2 | 1 | 2010 | 156 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2019 | 2187 | 0.020 |
Why?
|
Contraception | 1 | 2012 | 347 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 465 | 0.020 |
Why?
|
Gene Products, env | 1 | 2010 | 250 | 0.020 |
Why?
|
Measles | 1 | 2011 | 181 | 0.020 |
Why?
|
Efficiency | 1 | 2012 | 476 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2002 | 4571 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2009 | 6807 | 0.020 |
Why?
|
Rural Health Services | 1 | 2012 | 384 | 0.020 |
Why?
|
Neutralization Tests | 1 | 2010 | 725 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 2009 | 219 | 0.020 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 695 | 0.020 |
Why?
|
Infant Food | 1 | 2007 | 139 | 0.020 |
Why?
|
Public Policy | 1 | 2011 | 557 | 0.020 |
Why?
|
Abortion, Induced | 1 | 2012 | 461 | 0.020 |
Why?
|
Home Care Services | 1 | 2013 | 648 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 991 | 0.020 |
Why?
|
Focus Groups | 1 | 2012 | 1409 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1692 | 0.020 |
Why?
|
Food Microbiology | 1 | 2006 | 74 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2008 | 778 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4739 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2009 | 22148 | 0.020 |
Why?
|
Poverty Areas | 1 | 2006 | 263 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2012 | 1400 | 0.010 |
Why?
|
Water Supply | 1 | 2006 | 204 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.010 |
Why?
|
Diarrhea | 1 | 2011 | 1317 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2009 | 1185 | 0.010 |
Why?
|
Alcohol-Related Disorders | 1 | 2006 | 238 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1835 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8645 | 0.010 |
Why?
|
Data Collection | 1 | 2012 | 3315 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 809 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2013 | 5239 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2849 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2018 | 80566 | 0.010 |
Why?
|
Social Support | 1 | 2012 | 2174 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2011 | 2197 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2010 | 39063 | 0.010 |
Why?
|
Freezing | 1 | 2003 | 311 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18381 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 2002 | 317 | 0.010 |
Why?
|
Quality of Life | 1 | 2023 | 13347 | 0.010 |
Why?
|
Truth Disclosure | 1 | 2006 | 432 | 0.010 |
Why?
|
Proviruses | 1 | 2003 | 313 | 0.010 |
Why?
|
Child Behavior Disorders | 1 | 2006 | 804 | 0.010 |
Why?
|
Epitope Mapping | 1 | 2002 | 297 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3730 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7960 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2033 | 0.010 |
Why?
|
Fear | 1 | 2009 | 1477 | 0.010 |
Why?
|
Base Sequence | 1 | 2010 | 12421 | 0.010 |
Why?
|
Decision Making | 1 | 2012 | 3918 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4789 | 0.010 |
Why?
|
Tuberculosis | 1 | 2011 | 2015 | 0.010 |
Why?
|
Health Education | 1 | 2004 | 1049 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 6474 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2002 | 1865 | 0.010 |
Why?
|
Women's Health | 1 | 2006 | 2065 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2005 | 2299 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2002 | 1348 | 0.010 |
Why?
|
Viral Proteins | 1 | 2002 | 1799 | 0.010 |
Why?
|
Middle Aged | 3 | 2014 | 220584 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6561 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12447 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2002 | 3145 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2006 | 3735 | 0.010 |
Why?
|
Odds Ratio | 1 | 2006 | 9643 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7402 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10548 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16571 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12043 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2002 | 13441 | 0.010 |
Why?
|
Peptides | 1 | 2002 | 4354 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17629 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2006 | 15251 | 0.010 |
Why?
|
Incidence | 1 | 2006 | 21337 | 0.000 |
Why?
|
Aging | 1 | 2005 | 8699 | 0.000 |
Why?
|
Hospitalization | 1 | 2005 | 10704 | 0.000 |
Why?
|
Prognosis | 1 | 2005 | 29600 | 0.000 |
Why?
|
Aged | 1 | 2013 | 169042 | 0.000 |
Why?
|